englishEn

News

15.11.2017

Hemofarm Receives Recognition for Non-financial Reporting

The Responsible Business Forum, representing a network of socially responsible companies, presented a recognition to Hemofarm for contribution to the development of non-financial reporting in Serbia on 4 November 2017...
Learn more
15.11.2017

Serbian Citizens See Germany as the Most Desirable Investor

The German-Serbian Chamber of Commerce presented the results of the survey ’Serbian Citizens’ Perceptions of German Economy and Investments’ in Belgrade on November 14th, 2017, indicating that Germany is the most desirable investor and desired employer for Serbian citizens...
Learn more
26.10.2017

Certificate of Appreciation for Hemofarm

Marking its 50th anniversary, the Novi Sad Health Centre held a solemn ceremony on 25th October 2017. On that occasion, Veselin Bojat, Director of this institution, presented Hemofarm A.D. a Certificate of Appreciation as a symbol of long-lasting cooperation and support...
Learn more
19.10.2017

Hemofarm - Promoter of Sustainable Development in the Southeast Europe

Hemofarm presented its annual Sustainability Report for 2016 on October 19th in an event organized for partners and representatives of the media on a ship...
Learn more
28.09.2017

New Management of Company STADA Appointed

Dr. Claudio Albrecht appointed CEO and Mark Keatley CFO of STADA Arzneimittel AG. Five new Supervisory Board members appointed. Supervisory Board elects Dr. Günter von Au as new Chairman.
Learn more
18.08.2017

Minimum acceptance threshold for STADA takeover by Bain Capital and Cinven reached

Nidda Healthcare Holding AG, the acquiring company of Bain Capital und Cinven, announced today that the minimum acceptance threshold set by the bidder at 63 percent in the offer document published on July 19, 2017 was reached...
Learn more
04.08.2017

STADA Group business results in Q2 and the first six months of 2017

STADA shows good operational development in first six months of 2017
Learn more